Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
870 Leser
Artikel bewerten:
(2)

2CRSi SA: Estimated 2020/2021 consolidated annual results. Positive momentum in early 2021/2022.

DJ 2CRSi SA: Estimated 2020/2021 consolidated annual results. Positive momentum in early 2021/2022.

2CRSi SA 
2CRSi SA: Estimated 2020/2021 consolidated annual results. Positive momentum in early 2021/2022. 
15-Jun-2021 / 23:22 CET/CEST 
Dissemination of a French Regulatory News, transmitted by EQS Group. 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Press release 
Estimated 2020-21 annual results 
 
Estimated 2020/2021 consolidated annual results 
 - Revenue of EUR163.3m, in line with the revised target 
 - EBITDA of EUR7.3m, compared to EUR(2.4)m in 2019/2020 
 - EBITDA margin of 4.5%, up +7.5 points 
 - Exceptional provisions, pending settlement of the Blade situation 
 - Net income Group share of EUR(4.7)m 
Positive momentum in early 2021/2022 
 
 
 
Strasbourg (France), 15 June 2021 - 2CRSi (ISIN: FR0013341781), a designer and manufacturer of high-performance, 
energy-efficient servers, today presents its estimated results for the 2020/21 financial year (from 1 March 2020 to 28 
February 2021). 
 
2CRSi today announces its estimated annual results for the 2020/21 financial year. The Company has adopted a 
conservative approach in preparing these estimates. The audit is in progress. Audited consolidated accounts will be 
approved by the Board of Directors in the course of the month of June and will then give rise to a press release. 
As a reminder, financial year 2019/20 was marked by the acquisition of the Boston Limited group and had an exceptional 
duration of 14 months, from 1 January 2019 to 29 February 2020. Therefore, for comparability purposes, the 2019/20 
revenue below is presented on a pro forma[1] 12-month basis, from 1 March 2019 to 29 February 2020. 
HIGHLIGHTS OF THE 2020/2021 PERIOD: 
CONFIRMATION OF GOOD SALES MOMENTUM 
In a 2020/21 financial year marked by the health crisis, the Group estimated revenue increased by +15.8%. 
Including the contribution of the historical 2CRSi scope of EUR55.1 million and Boston Limited for EUR108.2 million, it 
came to EUR163.3m, compared to EUR141.1m pro forma over 12 months in 2019/20. A performance in line with the revised 
revenue target following the change in the situation of the Blade customer[2]. 
Over the period, the Group's activity was characterised by good sales momentum, particularly in the second half of the 
year. This was driven by the internationalisation of its activities and the diversification of its client portfolio, 
with the top 10 clients accounting for only 43% of the Group's revenues over the financial year, compared to 49% in the 
first half of 2020-21. All of the Group's subsidiaries, i.e. Boston Limited's value-added distribution and retail 
business as well as the historical scope of 2CRSi, posted growth over the year. 
As announced on 29 April 2021, this dynamic is illustrated in particular by major commercial successes in both the 
banking and cloud sectors, high-performance computing services and cryptocurrencies. These successes have more than 
offset the negative impact of COVID-19 and Blade in terms of activity. 
ESTIMATED 2020/21 RESULTS 
As a reminder, the 2019/20 period lasted 14 months (1 January 2019 to 29 February 2020), the end of its fiscal year 
having been set to end-February to align with that of Boston Limited and present its activities in a manner that is 
more consistent with the seasonal nature of its business, which is traditionally strong over the final months of the 
year. 
Operating expenses for 2019-20 are presented as corrected[3]. 
 
 
Simplified income statement -        Estimated 2020/21      2019/20 
                               2019/20 
In millions of EUR - IFRS          12 months          12 months 
                               14 months pro forma 
Revenue                   163.3       76.9   141.1 
Other ordinary operating income       3.9        1.7    0.9 
Revenue from ordinary activities      167.2       78.6   142.0 
Consumed purchases             (129.9)      (59.9)  (111.8) 
External charges              (9.4)       (8.2)   (11.7) 
Personnel expenses             (19.4)      (12.4)  (16.8) 
Tax                     (0.6)       (0.6)   (0.6) 
Other operating income and expenses     (0.6)       -     - 
EBITDA                   7.3        (2.4)   1.1 
EBITDA margin                4.5%       -3.1%   0.8% 
Other current operating income and expenses (0.2)       (0.6)   (0.6) 
Depreciation, amortisation and impairment  (6.6)       (5.1)   (4.8) 
Current operating income (expense)     0.5        (8.1)   (4.4) 
Operating profit              0.5        (8.3)   (4.5) 
Financial income (expense)         (5.4)       0.6    0.9 
Consolidated net income (expense)      (4.9)       (6.6)   (2.7) 
Net income (Group share)          (4.7)       (6.4)   (2.9) 

For fiscal year 2020/21, 2CRSi posted an estimated gross margin rate of 20.5% compared to 20.8% in 2019/20 (12 months pro forma).

Estimated external charges amounted to EUR(9.4)m, down 20% mainly linked to the decrease in marketing and travel expenses since March 2020 due to the pandemic.

Estimated payroll costs amounted to EUR(19.4)m, at 11.9% of Group revenue, compared with EUR(16.8)m and 11.9% of pro forma 2019/20 revenue. This increase reflects an overall increase in headcount, which reached 373 employees, compared to 355 at the end of February 2020. In particular, the sales and sales support teams were strengthened in the Middle East, the United States and Europe.

Estimated EBITDA for the financial year was EUR7.3m, up EUR6.2m compared to the pro forma for financial year 2019/20.

Estimated net depreciation and provisions are EUR(6.6)m. The increase compared to 2019/20 (12 months pro forma) was mainly due to additional depreciation expenses of EUR1.1m and operating provisions up EUR0.7 m.

Estimated operating income for the period is EUR0.5m.

Estimated financial income was negative at EUR(5.4)m. It was mainly affected by the impairment of Blade shares (EUR2m), impairment of financial receivables on Blade 2020 leases (EUR2.5m), foreign exchange losses (EUR0.5m) and a decline in financial income from equipment leases (-EUR0.2m).

Estimated consolidated net income (Group share) was EUR(4.7)m over the year. CASH POSITION AT END-MAY 2021

As of end of 31 May 2021, the Group's cash position was EUR10.9m. In addition, there are financing lines available for a total of EUR7.2 million (bank overdraft, undrawn short-term credit lines). IMPACT OF THE CURRENT GLOBAL SHORTAGE OF COMPONENTS

In connection with the health crisis and its consequences in terms of the disorganisation of worldwide logistics, in the first months of 2021 the shortage of electronic components continued and extended to now affect all data storage products (controllers, hard drives, flash drives) and processors in addition to graphic cards, memory modules and power supplies.

As already stated, although the situation calls for increased vigilance, 2CRSi currently has sufficient inventories (EUR32.2m at end-February 2021) to allow it to cope with the lengthened supply deadlines due to the shortage. A GROUP IN WORKING ORDER FOR 2021/22

The first months of 2021/22 were in line with the second half of the previous financial year, with positive commercial momentum. Among the major new orders registered, several contracts were won with CERN (European Organization for Nuclear Research) for an expected turnover that will exceed USD15 million over the current financial year, as well as with EdgeMode, an HPC and cryptocurrency company, for a total amount of USD2.3 million.

In addition to these recent commercial successes, 2CRSi is continuing its strategic investments in order to modernise its production facilities and accelerate its international growth. The Company recently announced that it won in a call for projects called "France Relance", with its "2CRSindustrie 4.0" project, aimed at digitising its industrial facilities and relocating the electronic production of some partners now carried out in Asia to Strasbourg; for this project, 2CRSi will receive a grant of EUR0.8 million.

The Group has also laid the groundwork for its green computing power offer in the North East of the United States with a datacenter in Rouses Point, in New York State, which will be the first stage of a campus including a production site, offices, training space, etc.

In total, several million euros in investments are planned, the results of which will be visible in the Group's results over the next six months and in the years to come.

- END -

Upcoming events: General Shareholders' Meeting on 31 August 2021.

About 2CRSi

Founded in Strasbourg (France), 2CRSi group develops, produces and sells customised, high-performance and environmental-friendly servers. In the 2020/2021 financial year, the Group generated revenue of EUR163 million The Group today has around 373 employees and markets its offer of innovative solutions (processing, storage and network) in more than 50 countries. 2CRSi has been listed since June 2018 on the regulated market of Euronext in Paris (ISIN Code: FR0013341781) and has been awarded the European Rising Tech label. For further information please visit: www.2crsi.com

Contacts 2CRSi

2CRSi           Actifin         Actifin 
Marie de Lauzon      Simon Derbanne      Jennifer Jullia 
Directeur Général Délégué Communication financière Relations Presse financière 
investors@2crsi.com    sderbanne@actifin.fr   jjullia@actifin.fr 
03 68 41 10 70      01 56 88 11 14      01 56 88 11 19 ----------------------------------------------------------------------------------------------------------------------- 

[1] The pro forma income statement for the 12 months from March 1, 2019 to February 29, 2020 has been prepared: - Based on the consolidated financial statements of the historical 2CRSi group for the 14-month period from which the

consolidated financial statements drawn up for the period from January 1, 2019 to February 28, 2019 on the same

scope have been deducted. - By adding the consolidated income statement of the Boston Ltd group for the period from March 1, 2019 to February

29, 2020, considering that the fair value adjustments determined as of November 18, 2019 would have been identical

as of March 1, 2019 (without taking into account the amortization of the customer relationship and the financial

expense of the accretion of the debt related to the put).

[2] As a reminder, on 3 March, 11 March and 5 May 2021, the Group published updates regarding the receivership of one of its main clients, Blade SAS, and then the declaration of bankruptcy of its American subsidiary, Blade Global Corp. In this context, for the 2020/21 financial year, computing servers ordered by Blade for an amount of EUR9.3 million could not be delivered to the client and therefore could not be recognised as revenue. The portion of the order not delivered to Blade, combined with delays in orders (signed since) related to the health context, had led 2CRSi to revise its 2020/21 revenue target between EUR162m and EUR175m.

[3] See press release of 29 April 2021. As part of the preparation of its annual financial statements at 28 February 2021, the company noted that operating expenses for the 2019/20 financial year were undervalued by EUR2.8m following the incorrect recognition of an asset receivable. This error gave rise to a correction of -EUR2.8m in EBITDA and -EUR2.1m in consolidated income for the year ended 29 February 2020 in the income statement presented. The consolidated balance sheet at 29 February 2020 was also amended. ----------------------------------------------------------------------------------------------------------------------- Regulatory filing PDF file File: 2CRSi - RA 2020-2021 EN

=---------------------------------------------------------------------- 
Language:    English 
Company:     2CRSi SA 
         32, rue Jacobi-Netter 
         67200 Strasbourg 
         France 
Phone:      +33 3 68 41 10 70 
E-mail:     investors@2crsi.com 
Internet:    www.2crsi.com 
ISIN:      FR0013341781 
Euronext Ticker: 2CRSI 
AMF Category:  Inside information / News release on accounts, results 
EQS News ID:   1208385 
 
End of Announcement EQS News Service 
=------------------------------------------------------------------------------------ 

1208385 15-Jun-2021 CET/CEST

Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1208385&application_name=news 
 

(END) Dow Jones Newswires

June 15, 2021 17:23 ET (21:23 GMT)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2021 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.